Production (Stage)
Moleculin Biotech, Inc.
MBRX
$0.67
-$0.0201-2.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.87M | 8.79M | 8.88M | 9.34M | 9.77M |
| Depreciation & Amortization | 124.00K | 125.00K | 129.00K | 130.00K | 130.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.91M | 26.64M | 28.92M | 27.73M | 27.95M |
| Operating Income | -25.91M | -26.64M | -28.92M | -27.73M | -27.95M |
| Income Before Tax | -23.23M | -21.76M | -30.15M | -25.17M | -26.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.23 | -21.76 | -30.15 | -25.17 | -26.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.23M | -21.76M | -30.15M | -25.17M | -26.82M |
| EBIT | -25.91M | -26.64M | -28.92M | -27.73M | -27.95M |
| EBITDA | -25.78M | -26.51M | -28.79M | -27.60M | -27.83M |
| EPS Basic | -5.61 | -6.94 | -11.65 | -11.62 | -12.94 |
| Normalized Basic EPS | -3.51 | -4.34 | -7.28 | -7.26 | -8.09 |
| EPS Diluted | -5.61 | -6.94 | -11.65 | -11.62 | -12.94 |
| Normalized Diluted EPS | -3.51 | -4.34 | -7.28 | -7.26 | -8.09 |
| Average Basic Shares Outstanding | 20.64M | 13.76M | 10.74M | 9.02M | 8.45M |
| Average Diluted Shares Outstanding | 20.64M | 13.76M | 10.74M | 9.02M | 8.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |